Planned Parenthood Sites and Grantees Withdrawing From Title X If Court Doesn’t Block New Regulations
Source Planned Parenthood Sites and Grantees Withdrawing from Title X Program If Court Does Not Block New Regulations
Abortion
The Abortion in the United States Dashboard is an ongoing research project tracking state abortion policies and litigation following the overturning of Roe v. Wade. It features a continuously-updated map tracking the status of abortion bans across the United States, as well as briefs on topics such as medication abortion, insurance coverage, ballot measures, legal developments, and racial and ethnic disparities. It also offers a jumping off point to the latest national and state-specific abortion policies and statistics. Visit the Dashboard →
View the Latest: Abortion
Filter
-
-
Abortion Coverage in the ACA Marketplace Plans: The Impact of Proposed Rules for Consumers, Insurers and Regulators
Issue BriefOn November 7, 2018, a day after the 2018 midterm elections, the Trump Administration issued a proposed regulation to address “Exchange Program Integrity.” A major element of this proposed rule would affect insurers, consumers, and state insurance regulators in the states that either allow or require abortion coverage. The Affordable Care Act (ACA) allows states to ban plans from offering abortion as a benefit on their Qualified Health Plans (QHPs) and requires plans that cover…
-
How State Policies Limiting Abortion Coverage Changed Over Time
FeatureThis week, the Trump administration proposed new rules around abortion coverage in the ACA Marketplace plans. Here’s how state policies shaping access to abortion coverage in Medicaid and private insurance have changed before and after the passage of the health law.
-
Q & A: Implications of Two Conflicting Federal Court Rulings on the Availability of Medication Abortion and the FDA’s Authority to Regulate Drugs
Policy WatchThis policy watch explains the two conflicting rulings on the provision of mifepristone issued by two separate District Courts on April 7, 2023, Alliance for Hippocratic Medicine v. FDA and State of Washington v. United States Food and Drug Administration.
-
Reading the Post-Roe Tea Leaves in States Without Abortion Bans or Protections
Policy WatchIn the 17 states without explicit laws prohibiting or protecting abortions, we present a number of indicators to assess abortion access, including abortion restrictions, the number of clinics and women of reproductive age per clinic, as well as State Supreme Court rulings interpreting the right to abortion in that state.
-
The Public, Including Women of Childbearing Age, Are Largely Confused About the Legality of Medication Abortion and Emergency Contraceptives in Their States
News ReleaseMore than six months since the Supreme Court issued their Dobbs decision which overturned Roe v. Wade, there is widespread public confusion about the medication abortion pill and whether it is legal at the state level, according to the latest KFF Health Tracking Poll. The poll also finds many are unsure about the legality of emergency contraceptive pills, sometimes called morning after pills or “Plan B,” and whether the pills can end a pregnancy. Across…
-
Leading up to the 50th Anniversary of the Now-Overturned Roe, New KFF Brief Presents an Analysis of Current Legal Challenges to State Abortion Bans
News ReleaseAs the nation marks the 50th anniversary of the Supreme Court of the United States landmark Roe v. Wade decision, which the Supreme Court overturned, 14 states have active litigation challenging state abortion bans and restrictions. A new KFF brief explains how individuals and organizations suing to block the bans are framing their legal challenges based on different state constitutional protections and state laws now that the battleground over abortion rights rests with states. The…
-
National and State Analysis of the Role of Health Care and Abortion in the Midterm Available through KFF Online Dashboard
News ReleaseSupplemental KFF Questions Added to AP VoteCast Survey Provide Deeper Insight About the Impact of Abortion and Health Care Issues Health Care Costs Were Among Economic Concerns for Voters Motivated by Inflation, and Abortion Was a Motivating Factor for Many Democratic Voters and Women Inflation was widely expected to be the driving issue for voters on Election Day, and poll results bear this out. However, beyond inflation, seven in ten voters said the Supreme Court’s…
-
Abortion Bans May Limit Access to Certain Drugs Used to Treat Women with Cancer, Autoimmune Diseases, and Ulcers
News ReleaseA new KFF analysis finds that women comprise the majority of patients who rely on certain drugs that may be restricted in response to state abortion bans. Following the Supreme Court decision to overturn Roe v. Wade, some women in abortion-banning states have reported that clinicians and pharmacists denied them access to medications like methotrexate and misoprostol that are used to manage chronic conditions but are also used for medication abortions and treatment of ectopic…
-
KFF Examines the Hyde Amendment and its Impact in States Without Abortion Bans
News ReleaseKFF takes a new look at the continued impact of the Hyde Amendment, the federal ban on payment for abortion services, in the wake of the Supreme Court’s Dobbs decision. At a moment when all eyes are on states that have banned abortion, the Hyde Amendment remains a barrier to abortion care for people with low incomes in states where abortion is legal but the state restricts Medicaid coverage to the narrow exceptions allowed under…